Key result
Atrial fibrillation and COVID-19 exhibit a detrimental clinical interplay, reflecting the established relationship between infectious diseases and arrhythmias.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Heightened AF monitoring may be prudent in COVID-19; leaves open whether targeted strategies improve outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Romiti et al. (2024) studied this question. Atrial fibrillation and COVID-19 exhibit a detrimental clinical interplay, reflecting the established relationship between infectious diseases and arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: